Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
May 1212:00 PM EDT
-11:59 PM EDT
Make the most of your break with the most realistic GMAT™ prep. Take up to $700 off select products.
May 1501:00 PM IST
-11:00 AM IST
Start your journey with a fully customized action plan and work with a dedicated mentor to achieve a 735+ score.
May 1810:00 AM PDT
-11:00 AM PDT
Join us in a live GMAT practice session and solve 25 challenging GMAT questions with other test takers in timed conditions, covering GMAT Quant, Data Sufficiency, Data Insights, Reading Comprehension, and Critical Reasoning questions.- May 19
12:00 PM PDT
-01:00 PM PDT
Scoring 329 on the GRE is not always about using more books, more courses, or a longer study plan. In this episode of GRE Success Talks, Ashutosh shares his GRE preparation strategy, study plan, and test-day experience, explaining how he kept his prep.... - Jun 10
06:00 AM PDT
-06:15 PM PDT
Register for the GMAT Club Virtual MBA Spotlight Fair – the world’s premier event for serious MBA candidates. This is your chance to hear directly from Admissions Directors at nearly every Top 30 MBA program..
21 Aug 2025, 21:00
Kudos
Bookmarks
The system used by American venture capitalists is often lauded for its dynamism, high risk tolerance, and capacity for swift scaling. Yet a body of longitudinal research suggests that the same model often encourages short-term exits, limiting the scope for sustainable growth. Indeed, data indicate that U.S. venture funding has soared in recent years, reflecting an unprecedented appetite for brisk expansions. This market-driven allocation mechanism—where venture firms channel funds into emerging businesses—sometimes prioritizes rapid valuations over long-term viability. However, no consensus exists on whether patient capital always outperforms aggressive scaling. In contrast, some analyses show that countries such as Finland rely more heavily on public-private partnerships that foster strategic mentorship and steady capital infusions, allowing entrepreneurs to refine their products and cultivate enduring customer bases. American investors, holding diversified stakes in many early-stage companies, often lack the bandwidth for deep, ongoing evaluations. As a result, they rely on immediate metrics such as monthly user growth, overshadowing broader indicators like robust team development or resilient supply chains. Consequently, valuations can fluctuate wildly in response to brief changes in consumer demand, fueling risky behavior and misallocation of capital toward trendy sectors while leaving potentially transformative, slower-growing fields underfunded.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital—such as employee training or team-building programs—are viewed as costs rather than investments. Startups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
According to the passage, which of the following is true of the internal capital-allocation system used by American startups?
A. It gives preference to non-quantifiable expenditures, thereby raising near-term costs.
B. It can exacerbate a narrow focus on immediate outcomes, causing underinvestment in vital long-range capabilities.
C. It can emphasize a near-term profitability model while ostensibly protecting separate budgets earmarked for long-range initiatives.
D. It sometimes constrains startups from investing in immediate operational needs, yet explicitly channels surplus cash toward intangible assets that secure future growth.
E. It offers more comprehensive evaluation methods for intangible assets than those utilized by public-private partnerships abroad.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital—such as employee training or team-building programs—are viewed as costs rather than investments. Startups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
According to the passage, which of the following is true of the internal capital-allocation system used by American startups?
A. It gives preference to non-quantifiable expenditures, thereby raising near-term costs.
B. It can exacerbate a narrow focus on immediate outcomes, causing underinvestment in vital long-range capabilities.
C. It can emphasize a near-term profitability model while ostensibly protecting separate budgets earmarked for long-range initiatives.
D. It sometimes constrains startups from investing in immediate operational needs, yet explicitly channels surplus cash toward intangible assets that secure future growth.
E. It offers more comprehensive evaluation methods for intangible assets than those utilized by public-private partnerships abroad.
21 Aug 2025, 21:00
Kudos
Bookmarks
Official Solution:
The system used by American venture capitalists is often lauded for its dynamism, high risk tolerance, and capacity for swift scaling. Yet a body of longitudinal research suggests that the same model often encourages short-term exits, limiting the scope for sustainable growth. Indeed, data indicate that U.S. venture funding has soared in recent years, reflecting an unprecedented appetite for brisk expansions. This market-driven allocation mechanism—where venture firms channel funds into emerging businesses—sometimes prioritizes rapid valuations over long-term viability. However, no consensus exists on whether patient capital always outperforms aggressive scaling. In contrast, some analyses show that countries such as Finland rely more heavily on public-private partnerships that foster strategic mentorship and steady capital infusions, allowing entrepreneurs to refine their products and cultivate enduring customer bases. American investors, holding diversified stakes in many early-stage companies, often lack the bandwidth for deep, ongoing evaluations. As a result, they rely on immediate metrics such as monthly user growth, overshadowing broader indicators like robust team development or resilient supply chains. Consequently, valuations can fluctuate wildly in response to brief changes in consumer demand, fueling risky behavior and misallocation of capital toward trendy sectors while leaving potentially transformative, slower-growing fields underfunded.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital—such as employee training or team-building programs—are viewed as costs rather than investments. Startups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
According to the passage, which of the following is true of the internal capital-allocation system used by American startups?
A. It gives preference to non-quantifiable expenditures, thereby raising near-term costs.
B. It can exacerbate a narrow focus on immediate outcomes, causing underinvestment in vital long-range capabilities.
C. It can emphasize a near-term profitability model while ostensibly protecting separate budgets earmarked for long-range initiatives.
D. It sometimes constrains startups from investing in immediate operational needs, yet explicitly channels surplus cash toward intangible assets that secure future growth.
E. It offers more comprehensive evaluation methods for intangible assets than those utilized by public-private partnerships abroad.
A) Incorrect: The passage states that intangible, non-quantifiable expenditures (e.g., training, research) are de-prioritized, not favored, when startups chase near-term metrics.
B) Correct Answer: The author argues in a few places that a narrow focus on immediate outcomes diverts funds away from long-range capabilities such as R&D and team development.
C) Incorrect: Although the system emphasizes near-term profitability, the passage indicates this does diminish resources for long-range initiatives rather than protecting separate budgets for them.
D) Incorrect: It reverses the passage’s logic: U.S. startups cut back on intangible-asset spending to cover short-term costs; they do not channel surplus cash toward such assets.
E) Incorrect: The author suggests U.S. startups rely on cruder short-term metrics, implying less, not more, sophisticated evaluation of intangible assets than patient-capital models abroad.
Answer: B
The system used by American venture capitalists is often lauded for its dynamism, high risk tolerance, and capacity for swift scaling. Yet a body of longitudinal research suggests that the same model often encourages short-term exits, limiting the scope for sustainable growth. Indeed, data indicate that U.S. venture funding has soared in recent years, reflecting an unprecedented appetite for brisk expansions. This market-driven allocation mechanism—where venture firms channel funds into emerging businesses—sometimes prioritizes rapid valuations over long-term viability. However, no consensus exists on whether patient capital always outperforms aggressive scaling. In contrast, some analyses show that countries such as Finland rely more heavily on public-private partnerships that foster strategic mentorship and steady capital infusions, allowing entrepreneurs to refine their products and cultivate enduring customer bases. American investors, holding diversified stakes in many early-stage companies, often lack the bandwidth for deep, ongoing evaluations. As a result, they rely on immediate metrics such as monthly user growth, overshadowing broader indicators like robust team development or resilient supply chains. Consequently, valuations can fluctuate wildly in response to brief changes in consumer demand, fueling risky behavior and misallocation of capital toward trendy sectors while leaving potentially transformative, slower-growing fields underfunded.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital—such as employee training or team-building programs—are viewed as costs rather than investments. Startups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
According to the passage, which of the following is true of the internal capital-allocation system used by American startups?
A. It gives preference to non-quantifiable expenditures, thereby raising near-term costs.
B. It can exacerbate a narrow focus on immediate outcomes, causing underinvestment in vital long-range capabilities.
C. It can emphasize a near-term profitability model while ostensibly protecting separate budgets earmarked for long-range initiatives.
D. It sometimes constrains startups from investing in immediate operational needs, yet explicitly channels surplus cash toward intangible assets that secure future growth.
E. It offers more comprehensive evaluation methods for intangible assets than those utilized by public-private partnerships abroad.
A) Incorrect: The passage states that intangible, non-quantifiable expenditures (e.g., training, research) are de-prioritized, not favored, when startups chase near-term metrics.
B) Correct Answer: The author argues in a few places that a narrow focus on immediate outcomes diverts funds away from long-range capabilities such as R&D and team development.
C) Incorrect: Although the system emphasizes near-term profitability, the passage indicates this does diminish resources for long-range initiatives rather than protecting separate budgets for them.
D) Incorrect: It reverses the passage’s logic: U.S. startups cut back on intangible-asset spending to cover short-term costs; they do not channel surplus cash toward such assets.
E) Incorrect: The author suggests U.S. startups rely on cruder short-term metrics, implying less, not more, sophisticated evaluation of intangible assets than patient-capital models abroad.
Answer: B
